Intra-Cellular Therapies Inc 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Mark Neumann | 10 | -181,034 |
Michael Halstead | 9 | -233,341 |
Sharon Mates | 9 | -554,970 |
Suresh K. Durgam | 9 | -129,431 |
Lawrence J. Hineline | 8 | -287,902 |
Joel S Marcus | 3 | -41,328 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 0 | 312,782 | -312,782 |
最近6个月 | 0 | 730,081 | -730,081 |
最近12个月 | 0 | 969,077 | -969,077 |
最近18个月 | 0 | 1,392,842 | -1,392,842 |
最近36个月 | 0 | 1,498,006 | -1,498,006 |
Intra-Cellular Therapies Inc 内部交易
Intra-Cellular Therapies Inc 最新内部交易
Suresh K. Durgam | EVP, Chief Medical Officer | 2024-03-11 | 卖出 | 10,162 | 19,803 |
$66.21
|
+8.99%
|
Mark Neumann | EVP, Chief Commercial Officer | 2024-03-11 | 卖出 | 20,477 | 29,700 |
$66.23
|
+8.95%
|
Michael Halstead | EVP & General Counsel | 2024-03-11 | 卖出 | 20,477 | - |
$66.09
|
+9.18%
|
Lawrence J. Hineline | SVP of Finance, CFO | 2024-03-11 | 卖出 | 23,253 | - |
$66.32
|
+8.81%
|
Sharon Mates | Chairman, President & CEO | 2024-03-11 | 卖出 | 61,277 | 1,050,309 |
$66.07
|
+9.22%
|
Van Nostrand Robert L | 董事 | 2024-02-27 | 卖出 | 20,000 | 9,611 |
$72.93
|
-1.06%
|
Joel S Marcus | 董事 | 2024-02-26 | 卖出 | 26,328 | 49,662 |
$68.68
|
+5.07%
|
Mark Neumann | EVP, Chief Commercial Officer | 2024-02-26 | 卖出 | 7,907 | 29,700 |
$70.13
|
+2.89%
|
Suresh K. Durgam | EVP, Chief Medical Officer | 2024-02-26 | 卖出 | 4,112 | 9,488 |
$70.17
|
+2.84%
|
Sharon Mates | Chairman, President & CEO | 2024-02-26 | 卖出 | 22,590 | 1,050,309 |
$69.79
|
+3.40%
|